Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2

Clinical trial NCT05482074 · WITHDRAWN

Trial details

NCT number: NCT05482074
Sponsor: Dana-Farber Cancer Institute
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Metastatic Melanoma Cutaneous Melanoma Mucosal Melanoma Uveal Melanoma

Start date: 2022-10-04
Primary completion: 2026-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.